Gilead Sciences (GILD) Depreciation & Amortization (CF) (2009 - 2026)

Gilead Sciences (GILD) has 18 years of Depreciation & Amortization (CF) data on file, last reported at $93.0 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 4.12% year-over-year to $93.0 million; the trailing twelve-month figure through Mar 2026 stood at $366.0 million (down 4.69% YoY), and the FY2025 full-year result was $370.0 million, down 2.89% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $93.0 million, up from $90.0 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $98.0 million in Q2 2024 and bottomed at $80.0 million in Q1 2022.
• The 5-year median for Depreciation & Amortization (CF) is $91.0 million (2023), against an average of $89.5 million.
• The widest annual swing landed in 2022, when Depreciation & Amortization (CF) declined 7.78%; it then rose 18.07% in 2024.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $83.0 million in 2022, then climbed by 9.64% to $91.0 million in 2023, then advanced by 4.4% to $95.0 million in 2024, then slipped by 5.26% to $90.0 million in 2025, then climbed by 3.33% to $93.0 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $93.0 million (Q1 2026), $90.0 million (Q4 2025), and $90.0 million (Q3 2025), per Business Quant data.

Peer Comparison